Many studies have shown that immune system modulation can be used to treat various forms of arthritis. A vasoactive intestinal peptide has recently been shown to have potent anti-inflammatory effects, indicating a new therapeutic approach for inflammatory arthritis (pages 563–568).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Firestein, G.S. Etiology and pathogenesis of rheumatoid arthritis. in Textbook of Rheumatology, 6th edn. (eds. Kelley, W.N et al.) 921–966 (W.B. Saunders, Philadelphia, 2001).
Delgado, M., Abad, C., Martinex, C., Leceta, J. & Gomariz, R.P. Vasoactive intestinal protein prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nature Med. 7, 563–568 (2001)
Firestein, G.S, Alvaro-Gracia, J.M. & Maki, R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144, 3347–3353 (1990).
Chabaud, M. et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42, 963–970 (1999).
Miossec, P. & van den Berg, W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 40, 2105–2015 (1997).
Gomariz, R.P., Martinez, C., Abad, C., Leceta, J. & Delgado, M. Immunology of VIP: a review and therapeutical perspectives. Curr. Pharm. Des. 7, 89–111 (2001).
Joosten, L. A. et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40, 249–260 (1997).
Boyle, D.L. et al. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced Th2 activity. Gene Ther. 6, 1911–1918 (1999).
Kong, Y.Y. et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304–309 (1999).
Dechanet, J. et al. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 24, 3222–3228 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Firestein, G. VIP: A very important protein in arthritis. Nat Med 7, 537–538 (2001). https://doi.org/10.1038/87859
Issue Date:
DOI: https://doi.org/10.1038/87859
This article is cited by
-
The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats
British Journal of Pharmacology (2005)